← All companies

ERAS

Erasca, Inc.

ERAS Nasdaq Pharmaceutical Preparations EDGAR ↗

$18.38

+0.54 +3.03%

Key statistics

from XBRL data in SEC filings

Market cap

$5.72B

Revenue (TTM)

—

Net income (TTM)

-$277M

EPS (TTM)

$-0.93

P/E ratio

—

Dividend yield

—

Free cash flow

-$95.6M

Cash

$47.3M

Total assets

$461M

Gross margin

—

52-week range

$1.33 – $24.28

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 14, 2026 8-K Other events Jul 13, 2026 8-K Shareholder vote results Jul 1, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Other events Apr 27, 2026 8-K Regulation FD disclosure; Other events Apr 27, 2026 8-K Other events Apr 21, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Other events Jan 29, 2026 8-K Other events Jan 22, 2026 8-K Results of operations (earnings release) Jan 20, 2026 8-K Regulation FD disclosure; Other events Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Shareholder vote results Jun 26, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Other events Oct 24, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Shareholder vote results Jun 24, 2024 8-K Other events Jun 24, 2024 8-K Other events May 17, 2024 8-K Entered a material agreement; Exit or disposal costs; Other events May 16, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Mar 28, 2024 10-K Fiscal year ended 2023-12-31 Mar 27, 2024 8-K Results of operations (earnings release) Mar 27, 2024 8-K Regulation FD disclosure Jan 9, 2024 8-K Other events Dec 11, 2023